SSH - ANN ARBOR — History
CCN 232024 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$22M
Latest Revenue (FY2022)
-4.1%
Revenue CAGR (3yr)
1.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $24M | $22M | -7.7% | -4.1% |
| Operating Expenses | $19M | $21M | $22M | +5.6% | +7.8% |
| Operating Margin | 21.8% | 13.6% | 1.2% | -91.4% | -76.8% |
| Net Income | $5M | $3M | $0M | -92.1% | -77.8% |
| Licensed Beds | 36 | 36 | 36 | +0.0% | +0.0% |
| Total Patient Days | 12,171 | 12,167 | 11,101 | -8.8% | -4.5% |
| Medicare Day % | 39% | 31% | 36% | +17.2% | -3.0% |
| Medicaid Day % | 0% | 0% | 0% | +64.4% | -22.7% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -8.0% ($24M → $22M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-4.1%
This Hospital
+7.6%
State Avg
Latest Margin
1.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $21M | -9.1% |
| FY2024 (proj) | $20M | -19.4% |
| FY2025 (proj) | $19M | -29.7% |